Numida meleagris isolate 19003 breed g44 Domestic line chromosome 10, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007823.2.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC110404572, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC110404572, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X4
sphingomyelin phosphodiesterase 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X5
protein arginine methyltransferase 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X3
protein arginine methyltransferase 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X10
protein arginine methyltransferase 7, transcript variant X11
protein arginine methyltransferase 7, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X9
protein arginine methyltransferase 7, transcript variant X1
solute carrier family 7 member 6 opposite strand
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
probable RNA polymerase II nuclear localization protein SLC7A6OS
solute carrier family 7 member 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
solute carrier family 7 member 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
solute carrier family 7 member 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
solute carrier family 7 member 6, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier family 7 member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 7 member 6, transcript variant X2
solute carrier family 7 member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
solute carrier family 7 member 6, transcript variant X3
toll-like receptor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC110404358, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC110404358, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC110404358, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC110404358, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC110404358, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC110404358, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
toll-like receptor 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
toll-like receptor 13, transcript variant X1
NDRG family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NDRG family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
NDRG family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
NDRG family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NDRG family member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NDRG family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
DNA replication complex GINS protein PSF3
uncharacterized LOC110404359, transcript variant X1
uncharacterized LOC110404359, transcript variant X4
uncharacterized LOC110404359, transcript variant X3
uncharacterized LOC110404359, transcript variant X2
coiled-coil domain containing 113, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
coiled-coil domain containing 113, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
coiled-coil domain containing 113, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
coiled-coil domain-containing protein 113 isoform X2
coiled-coil domain-containing protein 113 isoform X1
coiled-coil domain-containing protein 113 isoform X3
coiled-coil domain containing 113, transcript variant X2
coiled-coil domain containing 113, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
coiled-coil domain-containing protein 113 isoform X4
casein kinase 2 alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
casein kinase 2 alpha 2, transcript variant X1
casein kinase 2 alpha 2, transcript variant X3
casein kinase II subunit alpha' isoform X1
casein kinase II subunit alpha' isoform X2
casein kinase 2 alpha 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
casein kinase II subunit alpha' isoform X3
cilia and flagella associated protein 20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cilia- and flagella-associated protein 20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
zinc finger protein 319, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 319, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 319, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger protein 319, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
cyclic nucleotide-gated cation channel beta-1
kinesin family member C3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
kinesin family member C3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
kinesin family member C3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
kinesin family member C3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
kinesin family member C3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
kinesin family member C3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
kinesin family member C3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
katanin regulatory subunit B1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
katanin regulatory subunit B1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
katanin p80 WD40 repeat-containing subunit B1 isoform X2
katanin p80 WD40 repeat-containing subunit B1 isoform X1
dynein regulatory complex subunit 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
dynein regulatory complex subunit 7, transcript variant X4
dynein regulatory complex subunit 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
dynein regulatory complex subunit 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pancreatic secretory granule membrane major glycoprotein GP2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adhesion G protein-coupled receptor G3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
adhesion G protein-coupled receptor G5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adhesion G protein-coupled receptor G5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor G5, transcript variant X1
adhesion G-protein coupled receptor G5 isoform X1
adhesion G-protein coupled receptor G5 isoform X2
adhesion G-protein coupled receptor G5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
coiled-coil domain-containing protein 102A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB3
similar to RNA sequence (same species):INSD:GBYG01019025.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 613 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 190 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
ubiquinone biosynthesis protein COQ9, mitochondrial
cytokine induced apoptosis inhibitor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
cytokine induced apoptosis inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
glucose-fructose oxidoreductase domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
glucose-fructose oxidoreductase domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
glucose-fructose oxidoreductase domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucose-fructose oxidoreductase domain-containing protein 2 isoform X1
glucose-fructose oxidoreductase domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glucose-fructose oxidoreductase domain-containing protein 2 isoform X2
enkurin domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X8
chromosome 10 C16orf86 homolog, transcript variant X6
chromosome 10 C16orf86 homolog, transcript variant X4
chromosome 10 C16orf86 homolog, transcript variant X1
chromosome 10 C16orf86 homolog, transcript variant X2
uncharacterized protein C16orf86 homolog isoform X1
uncharacterized protein C16orf86 homolog isoform X2
chromosome 10 C16orf86 homolog, transcript variant X3
chromosome 10 C16orf86 homolog, transcript variant X5
uncharacterized protein C16orf86 homolog isoform X5
uncharacterized protein C16orf86 homolog isoform X4
uncharacterized protein C16orf86 homolog isoform X3
enkurin domain containing 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X1
enkurin domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X4
enkurin domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X9
par-6 family cell polarity regulator alpha, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
par-6 family cell polarity regulator alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
par-6 family cell polarity regulator alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
par-6 family cell polarity regulator alpha, transcript variant X1
partitioning defective 6 homolog alpha isoform X4
partitioning defective 6 homolog alpha isoform X3
partitioning defective 6 homolog alpha isoform X2
partitioning defective 6 homolog alpha isoform X1
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X1
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X4
NLR family CARD domain containing 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
family with sequence similarity 192 member A
ring finger and SPRY domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ring finger and SPRY domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
RING finger and SPRY domain-containing protein 1
ADP ribosylation factor like GTPase 2 binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ADP-ribosylation factor-like protein 2-binding protein
C-X3-C motif chemokine ligand 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
C-X3-C motif chemokine ligand 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RAN binding protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
RAN binding protein 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
RAN binding protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
RAN binding protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
translin associated factor X interacting protein 1, transcript variant X1
translin associated factor X interacting protein 1, transcript variant X3
translin associated factor X interacting protein 1, transcript variant X4
translin-associated factor X-interacting protein 1 isoform X1
translin-associated factor X-interacting protein 1 isoform X3
translin associated factor X interacting protein 1, transcript variant X2
translin-associated factor X-interacting protein 1 isoform X2
centromere protein T, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
centromere protein T, transcript variant X1
nuclear transport factor 2, transcript variant X3
nuclear transport factor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear transport factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear transport factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nuclear transport factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
enhancer of mRNA decapping 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
enhancer of mRNA decapping 4, transcript variant X1
enhancer of mRNA-decapping protein 4 isoform X2
enhancer of mRNA-decapping protein 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
exocyst complex component 3 like 1, transcript variant X1
exocyst complex component 3-like protein isoform X1
exocyst complex component 3 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
exocyst complex component 3 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
exocyst complex component 3-like protein isoform X3
exocyst complex component 3-like protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
transmembrane protein 208, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transmembrane protein 208, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA0895-like homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phosphatidylcholine-sterol acyltransferase
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GBYG01024841.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 89 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 89 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X2
RHO family interacting cell polarization regulator 1, transcript variant X4
RHO family interacting cell polarization regulator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
CCCTC-binding factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transcriptional repressor CTCF isoform X2
CCCTC-binding factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CCCTC-binding factor, transcript variant X4
CCCTC-binding factor, transcript variant X3
CCCTC-binding factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcriptional repressor CTCF isoform X1
capping protein regulator and myosin 1 linker 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
capping protein regulator and myosin 1 linker 2, transcript variant X3
capping protein regulator and myosin 1 linker 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X1
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X3
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
alanyl-tRNA synthetase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
alanyl-tRNA synthetase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
alanyl-tRNA synthetase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RNA-binding Raly-like protein, transcript variant X2
RNA-binding Raly-like protein, transcript variant X1
RNA-binding Raly-like protein isoform X2
heterogeneous nuclear ribonucleoprotein C-like isoform X1
C-type lectin domain family 18 member A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-type lectin domain family 18 member A-like, transcript variant X1
C-type lectin domain family 18 member A-like isoform X2
C-type lectin domain family 18 member A-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
zinc finger DHHC-type containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
zinc finger DHHC-type containing 1, transcript variant X1
zinc finger DHHC-type containing 1, transcript variant X3
probable palmitoyltransferase ZDHHC1 isoform X2
probable palmitoyltransferase ZDHHC1 isoform X1
probable palmitoyltransferase ZDHHC1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tubulin polymerization promoting protein family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tubulin polymerization promoting protein family member 3, transcript variant X1
tubulin polymerization-promoting protein family member 3
uncharacterized LOC110404507, transcript variant X7
uncharacterized LOC110404507, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC110404507, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC110404507, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC110404507, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110404507, transcript variant X1
uncharacterized LOC110404507, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
potassium channel tetramerization domain containing 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel tetramerization domain containing 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD19 isoform X1
BTB/POZ domain-containing protein KCTD19 isoform X3
potassium channel tetramerization domain containing 19, transcript variant X2
BTB/POZ domain-containing protein KCTD19 isoform X2
pleckstrin homology and RhoGEF domain containing G4, transcript variant X6
pleckstrin homology and RhoGEF domain containing G4, transcript variant X7
pleckstrin homology and RhoGEF domain containing G4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G4, transcript variant X2
pleckstrin homology and RhoGEF domain containing G4, transcript variant X1
solute carrier family 9 member A5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 9 member A5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
solute carrier family 9 member A5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
SNF-related serine/threonine-protein kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
SNF-related serine/threonine-protein kinase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SNF-related serine/threonine-protein kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
SNF-related serine/threonine-protein kinase-like isoform X2
SNF-related serine/threonine-protein kinase-like isoform X1
SET domain containing 6, transcript variant X2
SET domain containing 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
N-lysine methyltransferase SETD6 isoform X1
N-lysine methyltransferase SETD6 isoform X2
CCR4-NOT transcription complex subunit 1, transcript variant X9
CCR4-NOT transcription complex subunit 1, transcript variant X5
CCR4-NOT transcription complex subunit 1, transcript variant X3
CCR4-NOT transcription complex subunit 1, transcript variant X4
CCR4-NOT transcription complex subunit 1, transcript variant X6
CCR4-NOT transcription complex subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 1 isoform X8
CCR4-NOT transcription complex subunit 1 isoform X4
CCR4-NOT transcription complex subunit 1 isoform X6
CCR4-NOT transcription complex subunit 1 isoform X2
CCR4-NOT transcription complex subunit 1 isoform X7
CCR4-NOT transcription complex subunit 1 isoform X3
CCR4-NOT transcription complex subunit 1 isoform X5
CCR4-NOT transcription complex subunit 1 isoform X1
solute carrier family 38 member 7, transcript variant X2
solute carrier family 38 member 7, transcript variant X1
putative sodium-coupled neutral amino acid transporter 7 isoform X2
putative sodium-coupled neutral amino acid transporter 7 isoform X1
aspartate aminotransferase, mitochondrial
similar to RNA sequence (same species):INSD:GBYG01006669.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 102 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 88 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
purine nucleoside phosphorylase, transcript variant X6
purine nucleoside phosphorylase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
purine nucleoside phosphorylase, transcript variant X4
purine nucleoside phosphorylase, transcript variant X5
purine nucleoside phosphorylase, transcript variant X1
purine nucleoside phosphorylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
purine nucleoside phosphorylase isoform X2
purine nucleoside phosphorylase isoform X1
purine nucleoside phosphorylase isoform X3
cap methyltransferase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cap methyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cap methyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
HYDIN, axonemal central pair apparatus protein, transcript variant X3
HYDIN, axonemal central pair apparatus protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X14
HYDIN, axonemal central pair apparatus protein, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X1
HYDIN, axonemal central pair apparatus protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
HYDIN, axonemal central pair apparatus protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
hydrocephalus-inducing protein homolog isoform X1
hydrocephalus-inducing protein homolog isoform X2
hydrocephalus-inducing protein homolog isoform X3
hydrocephalus-inducing protein homolog isoform X4
hydrocephalus-inducing protein homolog isoform X5
hydrocephalus-inducing protein homolog isoform X6
hydrocephalus-inducing protein homolog isoform X7
hydrocephalus-inducing protein homolog isoform X8
hydrocephalus-inducing protein homolog isoform X9
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
conserved oligomeric Golgi complex subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X1
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X2
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial isoform X1
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial isoform X2
golgi glycoprotein 1, transcript variant X1
golgi glycoprotein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
golgi glycoprotein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
golgi glycoprotein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
golgi glycoprotein 1, transcript variant X3
golgi glycoprotein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
golgi glycoprotein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ring finger and WD repeat domain 3, transcript variant X5
ring finger and WD repeat domain 3, transcript variant X3
ring finger and WD repeat domain 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ring finger and WD repeat domain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ring finger and WD repeat domain 3, transcript variant X1
ring finger and WD repeat domain 3, transcript variant X2
E3 ubiquitin-protein ligase RFWD3 isoform X2
E3 ubiquitin-protein ligase RFWD3 isoform X1
mixed lineage kinase domain like pseudokinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mixed lineage kinase domain like pseudokinase, transcript variant X1
mixed lineage kinase domain-like protein
WD repeat domain 59, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
WD repeat domain 59, transcript variant X1
WD repeat domain 59, transcript variant X2
WD repeat domain 59, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
WD repeat-containing protein 59 isoform X2
WD repeat-containing protein 59 isoform X4
WD repeat-containing protein 59 isoform X1
WD repeat-containing protein 59 isoform X3
similar to RNA sequence (same species):INSD:GBYG01033735.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 281 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
probable D-lactate dehydrogenase, mitochondrial
breast cancer anti-estrogen resistance protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BCAR1, Cas family scaffolding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
BCAR1, Cas family scaffolding protein, transcript variant X2
breast cancer anti-estrogen resistance protein 1 isoform X2
breast cancer anti-estrogen resistance protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 12 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 12 member 3, transcript variant X1
solute carrier family 12 member 3 isoform X2
solute carrier family 12 member 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear pore complex protein Nup93 isoform X1
nuclear pore complex protein Nup93 isoform X2
2-oxoglutarate and iron dependent oxygenase domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
2-oxoglutarate and iron dependent oxygenase domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 5
autocrine motility factor receptor, transcript variant X1
E3 ubiquitin-protein ligase AMFR isoform X1
autocrine motility factor receptor, transcript variant X2
E3 ubiquitin-protein ligase AMFR isoform X2
G protein subunit alpha o1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
G protein subunit alpha o1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
G protein subunit alpha o1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha isoform X4
guanine nucleotide-binding protein G(o) subunit alpha isoform X2
guanine nucleotide-binding protein G(o) subunit alpha isoform X1
G protein subunit alpha o1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha isoform X3
core-binding factor beta subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
core-binding factor beta subunit, transcript variant X2
core-binding factor subunit beta isoform X1
core-binding factor subunit beta isoform X2
chromosome 10 C16orf70 homolog, transcript variant X3
chromosome 10 C16orf70 homolog, transcript variant X1
UPF0183 protein C16orf70 homolog isoform X1
UPF0183 protein C16orf70 homolog isoform X3
chromosome 10 C16orf70 homolog, transcript variant X2
UPF0183 protein C16orf70 homolog isoform X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
TNFRSF1A associated via death domain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
TNFRSF1A associated via death domain, transcript variant X1
tumor necrosis factor receptor type 1-associated DEATH domain protein
F-box and leucine rich repeat protein 8, transcript variant X4
F-box and leucine rich repeat protein 8, transcript variant X2
F-box and leucine rich repeat protein 8, transcript variant X3
F-box and leucine rich repeat protein 8, transcript variant X1
heat shock transcription factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
heat shock transcription factor 4, transcript variant X2
dynein axonemal assembly factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
dynein axonemal assembly factor 1, transcript variant X4
dynein axonemal assembly factor 1, transcript variant X2
dynein axonemal assembly factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
dynein axonemal assembly factor 1, transcript variant X5
dynein assembly factor 1, axonemal isoform X1
dynein assembly factor 1, axonemal isoform X3
dynein assembly factor 1, axonemal isoform X2
dynein assembly factor 1, axonemal isoform X4
hydroxysteroid dehydrogenase like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hydroxysteroid dehydrogenase like 1, transcript variant X2
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X1
hydroxysteroid dehydrogenase like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
hydroxysteroid dehydrogenase like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X2
membrane bound transcription factor peptidase, site 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
membrane-bound transcription factor site-1 protease
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
putative sodium-coupled neutral amino acid transporter 8
N-terminal EF-hand calcium binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
N-terminal EF-hand calcium-binding protein 2 isoform X2
N-terminal EF-hand calcium binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 2, transcript variant X3
N-terminal EF-hand calcium-binding protein 2 isoform X1
N-terminal EF-hand calcium-binding protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
oxidative stress induced growth inhibitor 1, transcript variant X1
oxidative stress induced growth inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
oxidative stress-induced growth inhibitor 1
receptor-interacting serine/threonine-protein kinase 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: receptor-interacting serine/threonine-protein kinase 2-like
coiled-coil domain-containing protein 81-like, transcript variant X1
coiled-coil domain-containing protein 81-like, transcript variant X2
coiled-coil domain-containing protein 81-like isoform X2
coiled-coil domain-containing protein 81-like isoform X1
uncharacterized LOC110404280, transcript variant X1
uncharacterized LOC110404280, transcript variant X2
epithelial splicing regulatory protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X2
epithelial splicing regulatory protein 2, transcript variant X3
epithelial splicing regulatory protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
epithelial splicing regulatory protein 2 isoform X1
epithelial splicing regulatory protein 2 isoform X2
epithelial splicing regulatory protein 2 isoform X3
epithelial splicing regulatory protein 2 isoform X4
epithelial splicing regulatory protein 2 isoform X5
nuclear factor of activated T-cells 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor of activated T-cells 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 3 isoform X2
nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
dihydrouridine synthase 2, transcript variant X2
dihydrouridine synthase 2, transcript variant X1
dihydrouridine synthase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dihydrouridine synthase 2, transcript variant X5
dihydrouridine synthase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X3
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable ATP-dependent RNA helicase DDX28
galanin receptor type 1-like, transcript variant X2
galanin receptor type 1-like, transcript variant X1
uncharacterized LOC110404349, transcript variant X1
uncharacterized LOC110404349, transcript variant X2
dipeptidase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dipeptidase 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dipeptidase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dipeptidase 2-like, transcript variant X3
dipeptidase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dipeptidase 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 12 member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium-dependent noradrenaline transporter
lysophosphatidylcholine acyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
lysophosphatidylcholine acyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysophosphatidylcholine acyltransferase 2 isoform X1
lysophosphatidylcholine acyltransferase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
iroquois-class homeodomain protein IRX-6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110404434, transcript variant X9
uncharacterized LOC110404434, transcript variant X8
uncharacterized LOC110404434, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC110404434, transcript variant X1
uncharacterized LOC110404434, transcript variant X4
uncharacterized LOC110404434, transcript variant X14
uncharacterized LOC110404434, transcript variant X2
uncharacterized LOC110404434, transcript variant X15
uncharacterized LOC110404434, transcript variant X10
uncharacterized LOC110404434, transcript variant X3
uncharacterized LOC110404434, transcript variant X5
uncharacterized LOC110404434, transcript variant X6
uncharacterized LOC110404434, transcript variant X12
uncharacterized LOC110404434, transcript variant X7
iroquois homeobox 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
iroquois homeobox 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-5 isoform X2
iroquois-class homeodomain protein IRX-5 isoform X1
uncharacterized LOC110404434, transcript variant X13
uncharacterized LOC110404340, transcript variant X2
uncharacterized LOC110404340, transcript variant X1
uncharacterized LOC110404340, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-3
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X6
alpha-ketoglutarate-dependent dioxygenase FTO isoform X2
alpha-ketoglutarate-dependent dioxygenase FTO isoform X1
alpha-ketoglutarate-dependent dioxygenase FTO isoform X4
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X3
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase FTO isoform X3
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X10
alpha-ketoglutarate-dependent dioxygenase FTO isoform X7
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X8
alpha-ketoglutarate-dependent dioxygenase FTO isoform X6
FTO, alpha-ketoglutarate dependent dioxygenase, transcript variant X7
alpha-ketoglutarate-dependent dioxygenase FTO isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110404555, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110404555, transcript variant X2
AKT interacting protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
AKT interacting protein, transcript variant X6
AKT interacting protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
AKT interacting protein, transcript variant X1
AKT interacting protein, transcript variant X2
AKT interacting protein, transcript variant X3
AKT interacting protein, transcript variant X5
AKT interacting protein, transcript variant X7
RB transcriptional corepressor like 2, transcript variant X1
retinoblastoma-like protein 2 isoform X1
RB transcriptional corepressor like 2, transcript variant X2
retinoblastoma-like protein 2 isoform X2
chromodomain helicase DNA binding protein 9, transcript variant X8
chromodomain helicase DNA binding protein 9, transcript variant X5
chromodomain helicase DNA binding protein 9, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X7
chromodomain helicase DNA binding protein 9, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X2
chromodomain helicase DNA binding protein 9, transcript variant X3
chromodomain helicase DNA binding protein 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X10
chromodomain helicase DNA binding protein 9, transcript variant X11
chromodomain-helicase-DNA-binding protein 9 isoform X5
chromodomain-helicase-DNA-binding protein 9 isoform X2
chromodomain-helicase-DNA-binding protein 9 isoform X6
chromodomain-helicase-DNA-binding protein 9 isoform X4
chromodomain-helicase-DNA-binding protein 9 isoform X3
chromodomain-helicase-DNA-binding protein 9 isoform X1
chromodomain-helicase-DNA-binding protein 9 isoform X7
chromodomain-helicase-DNA-binding protein 9 isoform X8
uncharacterized LOC110404546, transcript variant X4
uncharacterized LOC110404546, transcript variant X1
uncharacterized LOC110404546, transcript variant X3
uncharacterized LOC110404546, transcript variant X2
TOX high mobility group box family member 3, transcript variant X3
TOX high mobility group box family member 3, transcript variant X4
TOX high mobility group box family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X2
TOX high mobility group box family member 3 isoform X1
TOX high mobility group box family member 3 isoform X2
TOX high mobility group box family member 3 isoform X3
TOX high mobility group box family member 3 isoform X4
uncharacterized LOC110404523, transcript variant X1
uncharacterized LOC110404523, transcript variant X3
uncharacterized LOC110404523, transcript variant X2
spalt like transcription factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
spalt like transcription factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
spalt like transcription factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC110404383, transcript variant X3
uncharacterized LOC110404383, transcript variant X2
uncharacterized LOC110404383, transcript variant X1
uncharacterized LOC110404383, transcript variant X4
CYLD lysine 63 deubiquitinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
CYLD lysine 63 deubiquitinase, transcript variant X1
CYLD lysine 63 deubiquitinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
uncharacterized LOC110404386, transcript variant X1
uncharacterized LOC110404386, transcript variant X2
uncharacterized LOC110404385, transcript variant X1
uncharacterized LOC110404385, transcript variant X2
uncharacterized LOC110404385, transcript variant X4
uncharacterized LOC110404385, transcript variant X3
naked cuticle homolog 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
naked cuticle homolog 1, transcript variant X1
naked cuticle homolog 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein naked cuticle homolog 1 isoform X2
protein naked cuticle homolog 1 isoform X1
protein naked cuticle homolog 1 isoform X3
bromodomain containing 7, transcript variant X2
bromodomain containing 7, transcript variant X3
bromodomain containing 7, transcript variant X1
bromodomain-containing protein 7 isoform X2
bromodomain-containing protein 7 isoform X3
bromodomain-containing protein 7 isoform X1
adenylate cyclase 7, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
adenylate cyclase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adenylate cyclase 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenylate cyclase 7, transcript variant X5
adenylate cyclase 7, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adenylate cyclase 7, transcript variant X10
adenylate cyclase 7, transcript variant X8
adenylate cyclase 7, transcript variant X4
adenylate cyclase 7, transcript variant X2
adenylate cyclase 7, transcript variant X3
adenylate cyclase 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
poly(A) RNA polymerase D5, non-canonical
non-canonical poly(A) RNA polymerase PAPD5
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X2
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
nuclear envelope phosphatase-regulatory subunit 1 isoform X2
nuclear envelope phosphatase-regulatory subunit 1 isoform X1
zinc finger protein 423, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 423, transcript variant X1
zinc finger protein 423, transcript variant X4
zinc finger protein 423, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
zinc finger protein 423, transcript variant X9
zinc finger protein 423, transcript variant X7
zinc finger protein 423, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 423, transcript variant X5
zinc finger protein 423, transcript variant X8
uncharacterized LOC110404369, transcript variant X2
uncharacterized LOC110404369, transcript variant X10
uncharacterized LOC110404369, transcript variant X7
uncharacterized LOC110404369, transcript variant X8
uncharacterized LOC110404369, transcript variant X3
uncharacterized LOC110404369, transcript variant X6
uncharacterized LOC110404369, transcript variant X5
uncharacterized LOC110404369, transcript variant X4
uncharacterized LOC110404369, transcript variant X1
uncharacterized LOC110404369, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
siah E3 ubiquitin protein ligase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
siah E3 ubiquitin protein ligase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
siah E3 ubiquitin protein ligase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
E3 ubiquitin-protein ligase SIAH1 isoform X1
siah E3 ubiquitin protein ligase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
E3 ubiquitin-protein ligase SIAH1 isoform X2
E3 ubiquitin-protein ligase SIAH1 isoform X3
lon peptidase 2, peroxisomal, transcript variant X2
lon peptidase 2, peroxisomal, transcript variant X1
lon protease homolog 2, peroxisomal isoform X1
lon protease homolog 2, peroxisomal isoform X2
phosphorylase kinase regulatory subunit beta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
phosphorylase kinase regulatory subunit beta, transcript variant X5
phosphorylase kinase regulatory subunit beta, transcript variant X1
phosphorylase kinase regulatory subunit beta, transcript variant X2
phosphorylase kinase regulatory subunit beta, transcript variant X3
phosphorylase kinase regulatory subunit beta, transcript variant X4
phosphorylase b kinase regulatory subunit beta isoform X3
phosphorylase b kinase regulatory subunit beta isoform X1
phosphorylase b kinase regulatory subunit beta isoform X4
phosphorylase b kinase regulatory subunit beta isoform X2
integrin alpha FG-GAP repeat containing 1
neuropilin and tolloid like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
neuropilin and tolloid-like protein 2 isoform X3
neuropilin and tolloid like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
neuropilin and tolloid like 2, transcript variant X1
neuropilin and tolloid like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
neuropilin and tolloid-like protein 2 isoform X1
neuropilin and tolloid-like protein 2 isoform X2
neuropilin and tolloid-like protein 2 isoform X4
DnaJ heat shock protein family (Hsp40) member A2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
chromosome 10 C16orf87 homolog, transcript variant X4
chromosome 10 C16orf87 homolog, transcript variant X3
chromosome 10 C16orf87 homolog, transcript variant X1
chromosome 10 C16orf87 homolog, transcript variant X2
UPF0547 protein C16orf87 homolog isoform X1
chromosome 10 C16orf87 homolog, transcript variant X5
UPF0547 protein C16orf87 homolog isoform X2
myosin light chain kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
myosin light chain kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
origin recognition complex subunit 6, transcript variant X2
origin recognition complex subunit 6, transcript variant X1
origin recognition complex subunit 6 isoform X2
origin recognition complex subunit 6 isoform X1
vacuolar protein sorting-associated protein 35
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histamine H3 receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC110404425, transcript variant X1
uncharacterized LOC110404425, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial
V-set and transmembrane domain containing 2B
similar to RNA sequence (same species):INSD:GBYG01031520.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 47 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 47 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
V-set and transmembrane domain-containing protein 2B
POP4 homolog, ribonuclease P/MRP subunit
pleckstrin homology and FYVE domain containing 1, transcript variant X2
pleckstrin homology and FYVE domain containing 1, transcript variant X1
pleckstrin homology domain-containing family F member 1
protein C19orf12 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein C19orf12 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
protein C19orf12 homolog, transcript variant X2
protein C19orf12 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein F13E9.13, mitochondrial-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: protein C19orf12 homolog
similar to RNA sequence (same species):INSD:GBYG01012298.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 173 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 157 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
URI1, prefoldin like chaperone, transcript variant X1
URI1, prefoldin like chaperone, transcript variant X2
unconventional prefoldin RPB5 interactor 1 isoform X1
unconventional prefoldin RPB5 interactor 1 isoform X2
zinc finger protein 536, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 536, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 536, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 536, transcript variant X5
zinc finger protein 536, transcript variant X1
zinc finger protein 536, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 536, transcript variant X8
zinc finger protein 536, transcript variant X6
uncharacterized LOC110404499, transcript variant X1
uncharacterized LOC110404499, transcript variant X2
uncharacterized LOC110404481, transcript variant X3
uncharacterized LOC110404481, transcript variant X4
uncharacterized LOC110404481, transcript variant X1
uncharacterized LOC110404481, transcript variant X2
uncharacterized LOC110404591, transcript variant X1
uncharacterized LOC110404591, transcript variant X2
zinc finger protein 507, transcript variant X1
zinc finger protein 507, transcript variant X2
dpy-19 like 3 (C. elegans), transcript variant X4
dpy-19 like 3 (C. elegans), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dpy-19 like 3 (C. elegans), transcript variant X2
dpy-19 like 3 (C. elegans), transcript variant X1
probable C-mannosyltransferase DPY19L3 isoform X2
probable C-mannosyltransferase DPY19L3 isoform X1
probable C-mannosyltransferase DPY19L3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat domain 27, transcript variant X2
ankyrin repeat domain 27, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 27, transcript variant X1
ankyrin repeat domain 27, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ankyrin repeat domain-containing protein 27 isoform X1
ankyrin repeat domain-containing protein 27 isoform X2
ankyrin repeat domain 27, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
regulator of G protein signaling 9 binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 9-binding protein
nucleoside diphosphate-linked moiety X motif 19
tudor domain containing 12, transcript variant X1
tudor domain containing 12, transcript variant X4
tudor domain containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X3
tudor domain containing 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tudor domain containing 12, transcript variant X5
tudor domain containing 12, transcript variant X9
putative ATP-dependent RNA helicase TDRD12 isoform X2
putative ATP-dependent RNA helicase TDRD12 isoform X4
tudor domain containing 12, transcript variant X6
tudor domain containing 12, transcript variant X7
tudor domain containing 12, transcript variant X8
putative ATP-dependent RNA helicase TDRD12 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
centrosomal protein 89, transcript variant X2
centrosomal protein 89, transcript variant X1
centrosomal protein 89, transcript variant X5
centrosomal protein 89, transcript variant X4
centrosomal protein 89, transcript variant X6
centrosomal protein of 89 kDa isoform X2
centrosomal protein of 89 kDa isoform X1
centrosomal protein of 89 kDa isoform X4
centrosomal protein of 89 kDa isoform X5
centrosomal protein 89, transcript variant X3
centrosomal protein of 89 kDa isoform X3
uncharacterized LOC110404295, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC110404295, transcript variant X3
uncharacterized LOC110404295, transcript variant X1
Fanconi anemia core complex associated protein 24
Fanconi anemia core complex-associated protein 24
rhophilin Rho GTPase binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
rhophilin Rho GTPase binding protein 2, transcript variant X2
G-patch domain containing 1, transcript variant X2
G-patch domain containing 1, transcript variant X3
G-patch domain containing 1, transcript variant X4
G patch domain-containing protein 1 isoform X2
G-patch domain containing 1, transcript variant X1
G-patch domain containing 1, transcript variant X5
G patch domain-containing protein 1 isoform X1
G patch domain-containing protein 1 isoform X3
WD repeat domain 88, transcript variant X1
WD repeat domain 88, transcript variant X2
WD repeat-containing protein 88 isoform X2
WD repeat-containing protein 88 isoform X1
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110404436, transcript variant X1
uncharacterized LOC110404436, transcript variant X2
uncharacterized LOC110404436, transcript variant X3
uncharacterized LOC110404145, transcript variant X7
uncharacterized LOC110404145, transcript variant X6
uncharacterized LOC110404145, transcript variant X4
uncharacterized LOC110404145, transcript variant X1
uncharacterized LOC110404145, transcript variant X3
uncharacterized LOC110404145, transcript variant X2
uncharacterized LOC110404145, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
potassium channel tetramerization domain containing 15
similar to RNA sequence (same species):INSD:GBYG01033423.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 30 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 12 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
BTB/POZ domain-containing protein KCTD15
uncharacterized LOC110404078, transcript variant X2
uncharacterized LOC110404078, transcript variant X1
transcription initiation factor TFIID subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
LSM14A, mRNA processing body assembly factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
LSM14A, mRNA processing body assembly factor, transcript variant X1
LSM14A, mRNA processing body assembly factor, transcript variant X3
LSM14A, mRNA processing body assembly factor, transcript variant X2
LSM14A, mRNA processing body assembly factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
KIAA0355 ortholog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
KIAA0355 ortholog, transcript variant X1
KIAA0355 ortholog, transcript variant X2
KIAA0355 ortholog, transcript variant X5
KIAA0355 ortholog, transcript variant X4
KIAA0355 ortholog, transcript variant X6
KIAA0355 ortholog, transcript variant X7
uncharacterized protein KIAA0355 homolog isoform X1
uncharacterized protein KIAA0355 homolog isoform X2
WT1 interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WT1 interacting protein, transcript variant X1
Wilms tumor protein 1-interacting protein isoform X1
WT1 interacting protein, transcript variant X3
Wilms tumor protein 1-interacting protein isoform X2
ubiquitin like modifier activating enzyme 2
programmed cell death 2 like, transcript variant X2
similar to RNA sequence (same species):INSD:GBYG01012003.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 119 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
programmed cell death 2 like, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 119 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
programmed cell death 2 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 117 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
programmed cell death protein 2-like isoform X2
programmed cell death protein 2-like isoform X1
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain isoform X4
fatty acyl-CoA hydrolase precursor, medium chain isoform X2
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain isoform X3
fatty acyl-CoA hydrolase precursor, medium chain isoform X1
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X23
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X5
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X21
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X10
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X3
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X9
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X24
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X18
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain-like, transcript variant X12
fatty acyl-CoA hydrolase precursor, medium chain-like isoform X4
family with sequence similarity 96 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
mitotic spindle-associated MMXD complex subunit MIP18
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X3
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X1
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X2
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X5
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X4
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
NEDD8-activating enzyme E1 regulatory subunit
telomere repeat binding bouquet formation protein 1, transcript variant X5
telomere repeat binding bouquet formation protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
telomere repeat binding bouquet formation protein 1, transcript variant X4
telomere repeat binding bouquet formation protein 1, transcript variant X6
telomere repeat binding bouquet formation protein 1, transcript variant X7
telomere repeat binding bouquet formation protein 1, transcript variant X8
telomere repeat binding bouquet formation protein 1, transcript variant X9
telomere repeat binding bouquet formation protein 1, transcript variant X2
telomere repeat binding bouquet formation protein 1, transcript variant X3
telomere repeats-binding bouquet formation protein 1 isoform X3
telomere repeats-binding bouquet formation protein 1 isoform X8
telomere repeats-binding bouquet formation protein 1 isoform X4
telomere repeats-binding bouquet formation protein 1 isoform X7
telomere repeats-binding bouquet formation protein 1 isoform X1
telomere repeats-binding bouquet formation protein 1 isoform X6
telomere repeats-binding bouquet formation protein 1 isoform X2
telomere repeats-binding bouquet formation protein 1 isoform X5
dynein cytoplasmic 1 light intermediate chain 2
cytoplasmic dynein 1 light intermediate chain 2
CKLF like MARVEL transmembrane domain containing 4
CKLF-like MARVEL transmembrane domain-containing protein 4
CKLF like MARVEL transmembrane domain containing 3
CKLF-like MARVEL transmembrane domain-containing protein 3
thymidine kinase 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
thymidine kinase 2, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
thymidine kinase 2, mitochondrial isoform X1
thymidine kinase 2, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC110404589, transcript variant X1
uncharacterized LOC110404589, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC110404361, transcript variant X1
uncharacterized LOC110404361, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC110404437, transcript variant X7
uncharacterized LOC110404437, transcript variant X1
uncharacterized LOC110404437, transcript variant X6
uncharacterized LOC110404437, transcript variant X3
uncharacterized LOC110404437, transcript variant X2
uncharacterized LOC110404437, transcript variant X5
uncharacterized LOC110404437, transcript variant X4
uncharacterized LOC110404438, transcript variant X1
uncharacterized LOC110404438, transcript variant X4
uncharacterized LOC110404438, transcript variant X2
uncharacterized LOC110404438, transcript variant X3
uncharacterized LOC110404438, transcript variant X5
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X6
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X5
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X5
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X4
hypoxanthine-guanine phosphoribosyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nudix hydrolase 7, transcript variant X2
peroxisomal coenzyme A diphosphatase NUDT7 isoform X2
nudix hydrolase 7, transcript variant X3
nudix hydrolase 7, transcript variant X1
peroxisomal coenzyme A diphosphatase NUDT7 isoform X3
peroxisomal coenzyme A diphosphatase NUDT7 isoform X1
vesicle amine transport 1 like, transcript variant X1
vesicle amine transport 1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
synaptic vesicle membrane protein VAT-1 homolog-like isoform X1
synaptic vesicle membrane protein VAT-1 homolog-like isoform X2
C-type lectin domain family 3 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
C-type lectin domain family 3 member A isoform X1
C-type lectin domain family 3 member A, transcript variant X2
C-type lectin domain family 3 member A isoform X2
WW domain containing oxidoreductase, transcript variant X1
WW domain containing oxidoreductase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
WW domain-containing oxidoreductase isoform X1
WW domain containing oxidoreductase, transcript variant X3
WW domain-containing oxidoreductase isoform X2
MAF bZIP transcription factor, transcript variant X2
MAF bZIP transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
MAF bZIP transcription factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAF bZIP transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110404171, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC110404171, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC110404171, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
C-X9-C motif containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
C-X9-C motif containing 2, transcript variant X2
C-X9-C motif containing 2, transcript variant X3
COX assembly mitochondrial protein 2 homolog isoform X1
COX assembly mitochondrial protein 2 homolog isoform X2
centromere protein N, transcript variant X2
centromere protein N, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3E-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3E-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3E-like
glycine cleavage system H protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
polycystic kidney disease protein 1-like 2
beta-carotene oxygenase 1, transcript variant X3
beta-carotene oxygenase 1, transcript variant X1
beta-carotene oxygenase 1, transcript variant X2
beta,beta-carotene 15,15'-dioxygenase isoform X1
beta-carotene oxygenase 1, transcript variant X4
beta,beta-carotene 15,15'-dioxygenase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC110404258, transcript variant X1
uncharacterized LOC110404258, transcript variant X2
uncharacterized LOC110404257, transcript variant X1
uncharacterized LOC110404257, transcript variant X2
uncharacterized LOC110404257, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC110404257, transcript variant X3
c-Maf inducing protein, transcript variant X1
c-Maf inducing protein, transcript variant X2
phospholipase C gamma 2, transcript variant X1
phospholipase C gamma 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X1
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
short-chain dehydrogenase/reductase family 42E member 1
hydroxysteroid 17-beta dehydrogenase 2, transcript variant X3
hydroxysteroid 17-beta dehydrogenase 2, transcript variant X2
estradiol 17-beta-dehydrogenase 2 isoform X2
hydroxysteroid 17-beta dehydrogenase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
estradiol 17-beta-dehydrogenase 2 isoform X1
arylamine N-acetyltransferase, pineal gland isozyme NAT-3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
arylamine N-acetyltransferase, pineal gland isozyme NAT-3, transcript variant X2
arylamine N-acetyltransferase, liver isozyme, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
arylamine N-acetyltransferase, pineal gland isozyme NAT-3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme, transcript variant X5
arylamine N-acetyltransferase, liver isozyme, transcript variant X6
arylamine N-acetyltransferase, liver isozyme, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme
N-acetyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
N-acetyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
N-acetyltransferase 1, transcript variant X3
M-phase phosphoprotein 6, transcript variant X1
M-phase phosphoprotein 6, transcript variant X4
M-phase phosphoprotein 6, transcript variant X3
M-phase phosphoprotein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC110404367, transcript variant X2
uncharacterized LOC110404367, transcript variant X3
uncharacterized LOC110404367, transcript variant X1
uncharacterized LOC110404588, transcript variant X2
uncharacterized LOC110404588, transcript variant X1
malonyl-CoA decarboxylase, mitochondrial
uncharacterized LOC110404498, transcript variant X1
uncharacterized LOC110404498, transcript variant X2
uncharacterized LOC110404498, transcript variant X3
heat shock factor binding protein 1, transcript variant X2
heat shock factor binding protein 1, transcript variant X1
WAP four-disulfide core domain 1, transcript variant X4
WAP four-disulfide core domain 1, transcript variant X2
WAP four-disulfide core domain 1, transcript variant X3
potassium voltage-gated channel modifier subfamily G member 4
potassium voltage-gated channel subfamily G member 4
WAP four-disulfide core domain protein 1 isoform X2
WAP four-disulfide core domain protein 1 isoform X3
WAP four-disulfide core domain 1, transcript variant X1
WAP four-disulfide core domain protein 1 isoform X1
ATPase secretory pathway Ca2+ transporting 2, transcript variant X1
ATPase secretory pathway Ca2+ transporting 2, transcript variant X2
calcium-transporting ATPase type 2C member 2 isoform X2
calcium-transporting ATPase type 2C member 2 isoform X1
TBC/LysM-associated domain containing 1, transcript variant X2
TBC/LysM-associated domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
TBC/LysM-associated domain containing 1, transcript variant X1
TLD domain-containing protein 1 isoform X2
TLD domain-containing protein 1 isoform X1
coactosin like F-actin binding protein 1
kelch like family member 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
kelch like family member 36, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
kelch like family member 36, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC110404579, transcript variant X2
uncharacterized LOC110404579, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 10
cysteine rich secretory protein LCCL domain containing 2
cysteine-rich secretory protein LCCL domain-containing 2
hepatocyte nuclear factor 4-beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hepatocyte nuclear factor 4-beta-like, transcript variant X4
hepatocyte nuclear factor 4-beta-like, transcript variant X2
hepatocyte nuclear factor 4-beta-like, transcript variant X3
hepatocyte nuclear factor 4-beta-like isoform X2
hepatocyte nuclear factor 4-beta-like isoform X1
zinc finger DHHC-type containing 7, transcript variant X2
zinc finger DHHC-type containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
methenyltetrahydrofolate synthetase domain containing, transcript variant X4
methenyltetrahydrofolate synthetase domain containing, transcript variant X5
methenyltetrahydrofolate synthetase domain containing, transcript variant X3
methenyltetrahydrofolate synthetase domain containing, transcript variant X2
methenyltetrahydrofolate synthetase domain containing, transcript variant X1
methenyltetrahydrofolate synthetase domain containing, transcript variant X6
methenyltetrahydrofolate synthase domain-containing protein isoform X4
methenyltetrahydrofolate synthase domain-containing protein isoform X5
methenyltetrahydrofolate synthase domain-containing protein isoform X3
methenyltetrahydrofolate synthase domain-containing protein isoform X6
methenyltetrahydrofolate synthase domain-containing protein isoform X2
methenyltetrahydrofolate synthase domain-containing protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC110404350, transcript variant X2
uncharacterized LOC110404350, transcript variant X1
interferon regulatory factor 8, transcript variant X2
interferon regulatory factor 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
interferon regulatory factor 8, transcript variant X4
interferon regulatory factor 8, transcript variant X5
interferon regulatory factor 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
interferon regulatory factor 8 isoform X1
interferon regulatory factor 8 isoform X2
dual specificity protein phosphatase 22-A-like, transcript variant X2
dual specificity protein phosphatase 22-A-like, transcript variant X3
dual specificity protein phosphatase 22-A-like, transcript variant X1
dual specificity protein phosphatase 22-A-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dual specificity protein phosphatase 22-A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC110404409 isoform X2
uncharacterized protein LOC110404409 isoform X1
dual specificity protein phosphatase 22-A-like isoform X3
cytochrome c oxidase subunit 4 isoform 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
GINS complex subunit 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
DNA replication complex GINS protein PSF2 isoform X3
GINS complex subunit 2, transcript variant X3
GINS complex subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
GINS complex subunit 2, transcript variant X2
GINS complex subunit 2, transcript variant X4
GINS complex subunit 2, transcript variant X5
DNA replication complex GINS protein PSF2 isoform X1
DNA replication complex GINS protein PSF2 isoform X2
Gse1 coiled-coil protein, transcript variant X1
Gse1 coiled-coil protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
KIAA0513 ortholog, transcript variant X3
KIAA0513 ortholog, transcript variant X1
KIAA0513 ortholog, transcript variant X6
KIAA0513 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
KIAA0513 ortholog, transcript variant X5
KIAA0513 ortholog, transcript variant X4
uncharacterized protein KIAA0513 homolog isoform X2
uncharacterized protein KIAA0513 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
microtubule associated protein 1 light chain 3 beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
microtubule-associated proteins 1A/1B light chain 3B
zinc finger CCHC-type containing 14, transcript variant X3
zinc finger CCHC-type containing 14, transcript variant X2
zinc finger CCHC-type containing 14, transcript variant X1
zinc finger CCHC domain-containing protein 14
uncharacterized LOC110404306, transcript variant X2
uncharacterized LOC110404306, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01003008.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 494 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 380 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
kelch domain containing 4, transcript variant X1
kelch domain containing 4, transcript variant X4
kelch domain containing 4, transcript variant X2
kelch domain containing 4, transcript variant X5
kelch domain containing 4, transcript variant X3
kelch domain-containing protein 4 isoform X1
kelch domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
large neutral amino acids transporter small subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X9
BTG3 associated nuclear protein, transcript variant X10
BTG3 associated nuclear protein, transcript variant X1
BTG3 associated nuclear protein, transcript variant X2
BTG3 associated nuclear protein, transcript variant X3
BTG3 associated nuclear protein, transcript variant X4
BTG3 associated nuclear protein, transcript variant X5
BTG3 associated nuclear protein, transcript variant X11
BTG3 associated nuclear protein, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X15
BTG3 associated nuclear protein, transcript variant X14
BTG3 associated nuclear protein, transcript variant X18
BTG3 associated nuclear protein, transcript variant X16
BTG3 associated nuclear protein, transcript variant X17
BTG3 associated nuclear protein, transcript variant X19
BTG3 associated nuclear protein, transcript variant X7
BTG3 associated nuclear protein, transcript variant X8
BTG3 associated nuclear protein, transcript variant X6
BTG3 associated nuclear protein, transcript variant X12
zinc finger protein 469, transcript variant X3
zinc finger protein 469, transcript variant X1
zinc finger protein 469, transcript variant X2
zinc finger protein, FOG family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger protein, FOG family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cell death inducing DFFA like effector c
zinc finger CCCH-type containing 18, transcript variant X1
zinc finger CCCH-type containing 18, transcript variant X2
zinc finger CCCH-type containing 18, transcript variant X3
zinc finger CCCH-type containing 18, transcript variant X4
zinc finger CCCH domain-containing protein 18 isoform X1
zinc finger CCCH domain-containing protein 18 isoform X2
zinc finger CCCH domain-containing protein 18 isoform X3
zinc finger CCCH domain-containing protein 18 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01017282.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 82 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 58 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01002899.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 132 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cytosolic thiouridylase subunit 2, transcript variant X1
cytoplasmic tRNA 2-thiolation protein 2 isoform X1
cytosolic thiouridylase subunit 2, transcript variant X2
cytoplasmic tRNA 2-thiolation protein 2 isoform X2
piezo type mechanosensitive ion channel component 1, transcript variant X3
piezo type mechanosensitive ion channel component 1, transcript variant X2
piezo type mechanosensitive ion channel component 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
piezo-type mechanosensitive ion channel component 1 isoform X3
piezo-type mechanosensitive ion channel component 1 isoform X2
piezo-type mechanosensitive ion channel component 1 isoform X1
chromatin licensing and DNA replication factor 1, transcript variant X1
chromatin licensing and DNA replication factor 1, transcript variant X2
chromatin licensing and DNA replication factor 1, transcript variant X3
galactosamine (N-acetyl)-6-sulfatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
galactosamine (N-acetyl)-6-sulfatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
N-acetylgalactosamine-6-sulfatase isoform X1
N-acetylgalactosamine-6-sulfatase isoform X3
galactosamine (N-acetyl)-6-sulfatase, transcript variant X2
N-acetylgalactosamine-6-sulfatase isoform X2
trafficking protein particle complex 2 like
trafficking protein particle complex subunit 2-like protein
poly(A) binding protein nuclear 1 like, cytoplasmic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
embryonic polyadenylate-binding protein 2
CBFA2/RUNX1 translocation partner 3, transcript variant X6
CBFA2/RUNX1 translocation partner 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CBFA2/RUNX1 translocation partner 3, transcript variant X3
CBFA2/RUNX1 translocation partner 3, transcript variant X1
CBFA2/RUNX1 translocation partner 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CBFA2/RUNX1 translocation partner 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X2
acyl-CoA synthetase family member 3, transcript variant X1
acyl-CoA synthetase family member 3, transcript variant X3
acyl-CoA synthetase family member 3, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
putative solute carrier family 22 member 31
ankyrin repeat domain-containing protein 11
SPG7, paraplegin matrix AAA peptidase subunit, transcript variant X2
SPG7, paraplegin matrix AAA peptidase subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sulfotransferase family cytosolic 2B member 1-like, transcript variant X1
sulfotransferase family cytosolic 2B member 1-like, transcript variant X2
sulfotransferase family cytosolic 2B member 1-like isoform X1
sulfotransferase family cytosolic 2B member 1-like isoform X2
dipeptidase 1 (renal), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dipeptidase 1 (renal), transcript variant X2
cyclin dependent kinase 10, transcript variant X3
cyclin dependent kinase 10, transcript variant X2
cyclin dependent kinase 10, transcript variant X1
cyclin dependent kinase 10, transcript variant X5
cyclin dependent kinase 10, transcript variant X4
cyclin dependent kinase 10, transcript variant X6
spermatogenesis-associated protein 2-like protein
VPS9 domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
VPS9 domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
differentially expressed in FDCP 8 homolog
dysbindin domain containing 1, transcript variant X4
dysbindin domain containing 1, transcript variant X1
dysbindin domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dysbindin domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
dysbindin domain containing 1, transcript variant X2
dysbindin domain containing 1, transcript variant X5
dysbindin domain-containing protein 1 isoform X3
dysbindin domain-containing protein 1 isoform X2
dysbindin domain-containing protein 1 isoform X1
growth arrest specific 8, transcript variant X1
growth arrest-specific protein 8 isoform X1
growth arrest specific 8, transcript variant X2
growth arrest-specific protein 8 isoform X2
5-hydroxyisourate hydrolase-like, transcript variant X1
5-hydroxyisourate hydrolase-like, transcript variant X3
5-hydroxyisourate hydrolase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
5-hydroxyisourate hydrolase-like isoform X3
5-hydroxyisourate hydrolase-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
transport and golgi organization 6 homolog
transport and Golgi organization protein 6 homolog
chromosome transmission fidelity factor 8, transcript variant X1
chromosome transmission fidelity factor 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome transmission fidelity factor 8, transcript variant X2
chromosome transmission fidelity protein 8 homolog
UTP4, small subunit processome component
U3 small nucleolar RNA-associated protein 4 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
vacuolar protein sorting-associated protein 4A
component of oligomeric golgi complex 8, transcript variant X2
component of oligomeric golgi complex 8, transcript variant X1
conserved oligomeric Golgi complex subunit 8 isoform X1
conserved oligomeric Golgi complex subunit 8 isoform X2
NIP7, nucleolar pre-rRNA processing protein
60S ribosome subunit biogenesis protein NIP7 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane emp24 domain-containing protein 6
telomeric repeat binding factor 2, transcript variant X3
telomeric repeat binding factor 2, transcript variant X1
telomeric repeat binding factor 2, transcript variant X2
telomeric repeat-binding factor 2 isoform X3
telomeric repeat-binding factor 2 isoform X1
telomeric repeat-binding factor 2 isoform X2
telomeric repeat binding factor 2, transcript variant X4
telomeric repeat binding factor 2, transcript variant X5
telomeric repeat-binding factor 2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
nuclear factor of activated T-cells 5, transcript variant X1
nuclear factor of activated T-cells 5, transcript variant X2
nuclear factor of activated T-cells 5, transcript variant X3
nuclear factor of activated T-cells 5, transcript variant X4
nuclear factor of activated T-cells 5 isoform X1
nuclear factor of activated T-cells 5 isoform X2
nuclear factor of activated T-cells 5 isoform X3
nuclear factor of activated T-cells 5, transcript variant X5
nuclear factor of activated T-cells 5 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X1
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X3
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X1
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X3
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: zinc finger homeobox protein 3
uncharacterized LOC110404160, transcript variant X3
uncharacterized LOC110404160, transcript variant X1
uncharacterized LOC110404160, transcript variant X2
uncharacterized LOC110404162, transcript variant X2
uncharacterized LOC110404162, transcript variant X1
DEAH-box helicase 38, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
DEAH-box helicase 38, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16
dihydroorotate dehydrogenase (quinone), mitochondrial
IST1, ESCRT-III associated factor, transcript variant X1
IST1, ESCRT-III associated factor, transcript variant X2
IST1, ESCRT-III associated factor, transcript variant X3
IST1, ESCRT-III associated factor, transcript variant X4
IST1, ESCRT-III associated factor, transcript variant X5
zinc finger protein 821, transcript variant X7
zinc finger protein 821, transcript variant X3
zinc finger protein 821, transcript variant X4
zinc finger protein 821, transcript variant X5
zinc finger protein 821, transcript variant X6
zinc finger protein 821, transcript variant X10
zinc finger protein 821, transcript variant X1
zinc finger protein 821, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 821, transcript variant X8
zinc finger protein 821, transcript variant X2
zinc finger protein 821, transcript variant X11
adaptor related protein complex 1 gamma 1 subunit, transcript variant X2
adaptor related protein complex 1 gamma 1 subunit, transcript variant X1
adaptor related protein complex 1 gamma 1 subunit, transcript variant X4
adaptor related protein complex 1 gamma 1 subunit, transcript variant X3
adaptor related protein complex 1 gamma 1 subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X1
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X1
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: MARVEL domain-containing protein 3
tyrosine aminotransferase, transcript variant X4
tyrosine aminotransferase, transcript variant X1
tyrosine aminotransferase, transcript variant X2
tyrosine aminotransferase, transcript variant X5
tyrosine aminotransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carbohydrate sulfotransferase 4, transcript variant X2
carbohydrate sulfotransferase 4, transcript variant X1
carbohydrate sulfotransferase 4 isoform X1
carbohydrate sulfotransferase 4 isoform X2
telomeric repeat-binding factor 2-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
adenosine deaminase, tRNA specific 1, transcript variant X3
adenosine deaminase, tRNA specific 1, transcript variant X1
adenosine deaminase, tRNA specific 1, transcript variant X2
adenosine deaminase, tRNA specific 1, transcript variant X4
tRNA-specific adenosine deaminase 1 isoform X1
tRNA-specific adenosine deaminase 1 isoform X2
adenosine deaminase, tRNA specific 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
tRNA-specific adenosine deaminase 1 isoform X3
tRNA-specific adenosine deaminase 1 isoform X4
GABA type A receptor associated protein like 2, transcript variant X2
gamma-aminobutyric acid receptor-associated protein-like 2 isoform X2
GABA type A receptor associated protein like 2, transcript variant X3
gamma-aminobutyric acid receptor-associated protein-like 2 isoform X3
GABA type A receptor associated protein like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
gamma-aminobutyric acid receptor-associated protein-like 2 isoform X1
transmembrane protein 231, transcript variant X1
transmembrane protein 231, transcript variant X2
carbohydrate sulfotransferase 6-like, transcript variant X1
carbohydrate sulfotransferase 6-like, transcript variant X3
carbohydrate sulfotransferase 6-like, transcript variant X2
carbohydrate sulfotransferase 6-like isoform X2
carbohydrate sulfotransferase 6-like isoform X1
uncharacterized LOC110404536, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC110404536, transcript variant X1